Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists

被引:41
作者
Xin, Zhili [1 ]
Serby, Michael D. [1 ]
Zhao, Hongyu [1 ]
Kosogof, Christi [1 ]
Szczepankiewicz, Bruce G. [1 ]
Liu, Mei [1 ]
Liu, Bo [1 ]
Hutchins, Charles W. [1 ]
Sarris, Kathy A. [1 ]
Hoff, Ethan D. [1 ]
Falls, H. Douglas [1 ]
Lin, Chun W. [1 ]
Ogiela, Christopher A. [1 ]
Collins, Christine A. [1 ]
Brune, Michael E. [1 ]
Bush, Eugene N. [1 ]
Droz, Brian A. [1 ]
Fey, Thomas A. [1 ]
Knourek-Segel, Victoria E. [1 ]
Shapiro, Robin [1 ]
Jacobson, Peer B. [1 ]
Beno, David W. A. [1 ]
Turner, Teresa M. [1 ]
Sham, Hing L. [1 ]
Liu, Gang [1 ]
机构
[1] Abbott Labs, Metab Dis Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm060461g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery and pharmacological evaluation of potent, selective, and orally bioavailable growth hormone secretagogue receptor (GHS-R) antagonists are reported. Previously, 2,4-diaminopyrimidine-based GHS-R antagonists reported from our laboratories have been shown to be dihydrofolate reductase ( DHFR) inhibitors. By comparing the X-ray crystal structure of DHFR docked with our GHS-R antagonists and GHS-R modeling, we designed and synthesized a series of potent and DHFR selective GHS-R antagonists with good pharmacokinetic (PK) profiles. An amide derivative 13d (Ca2+ flux IC50) 188 nM, [brain]/[plasma]) = 0.97 @ 8 h in rat) showed a 10% decrease in 24 h food intake in rats, and over 5% body weight reduction after 14-day oral treatment in diet-induced obese (DIO) mice. In comparison, a urea derivative 14c (Ca2+ flux IC50) 7 nM, [brain]/[plasma]) = 0.0 in DIO) failed to show significant effect on food intake in the acute feeding DIO model. These observations demonstrated for the first time that peripheral GHS-R blockage with small molecule GHS-R antagonists might not be sufficient for suppressing appetite and inducing body weight reduction.
引用
收藏
页码:4459 / 4469
页数:11
相关论文
共 34 条
[1]   Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Yuzuriha, H ;
Nagata, T ;
Ueno, N ;
Makino, S ;
Fujimiya, M ;
Niijima, A ;
Fujino, MA ;
Kasuga, M .
GASTROENTEROLOGY, 2001, 120 (02) :337-345
[2]   Antagonism of ghrelin receptor reduces food intake and body weight gain in mice [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Kasuga, M .
GUT, 2003, 52 (07) :947-952
[3]   A NOVEL NON-PEPTIDYL GROWTH-HORMONE SECRETAGOGUE [J].
CHENG, K ;
CHAN, WWS ;
BUTLER, B ;
WEI, L ;
SMITH, RG .
HORMONE RESEARCH, 1993, 40 (1-3) :109-115
[4]   Ghrelin and energy balance: Focus on current controversies [J].
Cummings, DE ;
Foster-Schubert, KE ;
Overduin, J .
CURRENT DRUG TARGETS, 2005, 6 (02) :153-169
[5]   A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans [J].
Cummings, DE ;
Purnell, JQ ;
Frayo, RS ;
Schmidova, K ;
Wisse, BE ;
Weigle, DS .
DIABETES, 2001, 50 (08) :1714-1719
[6]   The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats [J].
Date, Y ;
Murakami, N ;
Toshinai, K ;
Matsukura, S ;
Niijima, A ;
Matsuo, H ;
Kangawa, K ;
Nakazato, M .
GASTROENTEROLOGY, 2002, 123 (04) :1120-1128
[7]   Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists:: 1H-Pyrimidin-2-one derivatives [J].
Geneste, H ;
Backfisch, G ;
Braje, W ;
Delzer, J ;
Haupt, A ;
Hutchins, CW ;
King, LL ;
Kling, A ;
Teschendorf, HR ;
Unger, L ;
Wernet, W .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) :490-494
[8]   STRUCTURAL STUDIES ON BIOACTIVE COMPOUNDS .8. SYNTHESIS, CRYSTAL-STRUCTURE, AND BIOLOGICAL PROPERTIES OF A NEW SERIES OF 2,4-DIAMINO-5-ARYL-6-ETHYLPYRIMIDINE DIHYDROFOLATE-REDUCTASE INHIBITORS WITH INVIVO ACTIVITY AGAINST A METHOTREXATE-RESISTANT TUMOR-CELL LINE [J].
GRIFFIN, RJ ;
MEEK, MA ;
SCHWALBE, CH ;
STEVENS, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (11) :2468-2474
[9]   STRUCTURAL STUDIES ON BIO-ACTIVE COMPOUNDS .3. RE-EXAMINATION OF THE HYDROLYSIS OF THE ANTIMALARIAL DRUG PYRIMETHAMINE AND RELATED DERIVATIVES AND CRYSTAL-STRUCTURE OF A HYDROLYSIS PRODUCT [J].
GRIFFIN, RJ ;
SCHWALBE, CH ;
STEVENS, MFG ;
WONG, KP .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1985, (11) :2267-2276
[10]  
HUTCHINS C, 1994, ENDOCRINE, V2, P7